Anne Novak

28PUBLICATIONS
140CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Disease surveillancePredictive and prognostic markersImmunogenetics (incl. genetic immunology)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 20, 2026
Malignant B-cell States Orchestrate Spatially Organized Immune Ecosystems in B-cell Lymphomas.

|Jun 24, 2026
No association of prior administration of selected vaccines with lymphoma prognosis.

|Mar 27, 2026
High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma Subtypes.

Arushi Khurana, Hikaru Hayashi, Bethany Thach

|Mar 24, 2026
Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation study.

Yolanda Benavente, Sara Hermosa, Nikos Papadimitriou

|Mar 10, 2026
Family history of haematological malignancy and prognosis across non-Hodgkin lymphoma subtypes.

George A Cholack, Raphael Mwangi, Prokop Vodička

|Feb 04, 2026
Malignant B cells expressing SIRPα are highly proliferative and are associated with inferior clinical outcomes in B-cell non-Hodgkin lymphoma.

Zhi-Zhang Yang, Hyo Jin Kim, Xinyi Tang

Pageof 5

Frequent Collaborators

20 joint publications

James R Cerhan

20 joint publications

Stephen M Ansell

16 joint publications

Matthew Maurer

13 joint publications

Thomas M Habermann